U.S. market Closed. Opens in 16 hours 58 minutes

AGIO | Agios Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue26.82M14.24MN/A203.20M117.91M94.39M43.01M69.89M59.12M65.36M25.55M25.11M21.84M
Cost of Revenue9.50M1.70M18.78M2.81M1.32M1.40MN/AN/AN/AN/AN/AN/AN/A
Gross Profit17.32M12.54M-18.78M200.39M116.59M92.99MN/AN/AN/AN/AN/AN/AN/A
Operating Expenses408.81M401.58M378.42M516.54M542.93M455.47M363.81M270.88M177.82M119.49M64.43M48.10M38.47M
Selling, General & Admin119.90M121.67M121.44M149.07M132.03M114.14M71.12M50.71M35.99M19.12M9.93M7.06M7.21M
Research & Development288.90M279.91M256.97M367.47M410.89M341.32M292.68M220.16M141.83M100.37M54.50M41.04M31.25M
Other Operating Expenses6.05M6.75M14.43MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-391.49M-389.05M-378.42M-316.15M-426.33M-362.48M-320.79M-200.99M-118.70M-54.13M-38.88M-23.00M-16.63M
Other Expenses / Income39.40M157.25M21.91M-11.22M14.86M16.45M6.12M2.51M968.00K203.00K55.00K69.00K132.00K
Before Tax Income-352.09M-231.80M-356.51M-327.37M-411.47M-346.03M-314.67M-198.47M-117.73M-53.93M-38.83M-22.93M-16.50M
Income Tax Expenses6.46M-157.25M-1.98B7.85M-14.86M32.90MN/AN/AN/A-426.00K579.00K-2.82M7.21M
Net Income-352.09M-74.56M1.60B-335.22M-396.61M-346.03M-314.67M-198.47M-117.73M-53.50M-39.41M-20.10M-23.71M
Interest ExpensesN/A12.79MN/A17.83MN/A16.45M6.12MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding55.65M54.79M60.45M69.00M59.99M57.42M46.59M39.13M37.43M33.67M15.41M23.13M23.39M
Diluted Shares Outstanding55.65M54.79M60.45M69.00M59.99M57.42M46.59M39.13M37.43M33.67M15.41M23.13M23.39M
EBITDA-384.86M-526.75M-385.06M-309.54M-418.25M-362.48M-302.11M-192.76M-114.39M-52.56M-37.39M-21.75M-15.70M
EBITDA Margin-1,434.83%-3,699.09%0.00%-152.33%-354.71%-384.03%-702.41%-275.80%-193.49%-80.42%-146.34%-86.62%-71.89%
EBIT-345.63M-219.01M-373.23M-309.54M-411.47M-296.68M-308.55M-198.47M-117.73M-53.93M-38.83M-22.93M-16.50M
EBIT Margin-1,288.57%-1,537.98%0.00%-152.33%-348.97%-314.32%-717.37%-283.97%-199.14%-82.51%-151.98%-91.32%-75.56%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙